Fig. 1From: The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage inducedCOVID-19 can cause direct liver damage, either through ACE-2 entry or indirect through generalized inflammation caused by the cytokine cascade. In addition, the administration of drugs with DILI potential may be an additional cause of liver damageBack to article page